A
Akilah R. Ali
Publications - 9
Citations - 283
Akilah R. Ali is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 9 publications receiving 283 citations.
Papers
More filters
Journal ArticleDOI
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021
Amelia G Johnson,Avnika B. Amin,Akilah R. Ali,Brooke E. Hoots,Betsy L. Cadwell,Shivani Arora,Tigran Avoundjian,Abiola O. Awofeso,Jason Barnes,Nagla S. Bayoumi,Katherine Busen,Carolyn Chang,Michael J. Cima,Molly J. Crockett,Alicia Cronquist,Sherri L. Davidson,Elizabeth M. Davis,Janelle Delgadillo,Vajeera Dorabawila,Cherie Drenzek,Leah Eisenstein,H. Fast,A. M. van Gent,Julie Hand,Dina Hoefer,Corinne Holtzman,Amanda Jara,Amanda B. Jones,Ishrat Kamal-Ahmed,Sarah Kangas,Fnu Kanishka,Ramandeep Kaur,S. Khan,Justice Eleanor King,Sam E. Kirkendall,Anna Klioueva,Anna Kocharian,Frances Y Kwon,Jacqueline Logan,B. Casey Lyons,S. L. Lyons,Andrea L. May,Donald McCormick,Erica Mendoza,Lauren Milroy,Allison T. O'Donnell,Melissa G. Pike,Sargis Pogosjans,Amy Saupe,Jessica Sell,E. Smith,Daniel M. Sosin,Emma Suzanne Stanislawski,Molly Steele,Meagan Stephenson,A. M. Stout,Kyle Strand,Buddhi Tilakaratne,Kathryn Turner,Hailey Vest,Sydni Warner,Caleb Wiedeman,Allison Zaldivar,Benjamin J. Silk,Heather M. Scobie +64 more
TL;DR: The highest impact of booster doses against infection and death compared with full vaccination without booster doses was recorded among persons aged 50-64 and ≥65 years, and eligibility to stay up to date with COVID-19 vaccinations.
Journal ArticleDOI
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 202
Ruth Link-Gelles,Allison A vrich Ciesla,Lauren Roper,Heather M. Scobie,Akilah R. Ali,Joseph D. Miller,Ryan E. Wiegand,Emma Accorsi,Jennifer R. Verani,Nong Shang,Gordana Derado,Amadea Britton,Zachary R Smith,Katherine E. Fleming-Dutra +13 more
TL;DR: In this paper , the SARS-CoV-2 Omicron sublineage XBB was first detected in the United States in August 2022 and XBB/XBB.1.5-related sublineages were identified in the increasing community access to testing (ICATT) national pharmacy program.
Journal ArticleDOI
COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022
Amelia G Johnson,Lauren Linde,Akilah R. Ali,Allison DeSantis,Minchan Shi,C. Adam,Brandy Armstrong,Brett Armstrong,Madison Asbell,Steven Auche,Nagla S. Bayoumi,Boudu G. Bingay,Melisse Chasse,Scott A. Christofferson,Michael J. Cima,Kevin Cueto,Spencer Cunningham,Janelle Delgadillo,Vajeera Dorabawila,Cherie Drenzek,Brandi Dupervil,Tonji Durant,Aaron T. Fleischauer,Ross Hamilton,P. Harrington,Liam Hicks,J. Hodis,Dina Hoefer,Samuel Horrocks,Mikhail Hoskins,Sofia Husain,L. Amanda Ingram,Amanda Jara,A. Jones,Fnu Kanishka,Ramandeep Kaur,Saadi Khan,Sam E. Kirkendall,Priscilla Lauro,S. L. Lyons,Joshua Mansfield,Amanda Markelz,Jan Masařík,Donald McCormick,Erica Mendoza,Keeley Morris,Enaholo Omoike,Komal Patel,M Pike,Tamara Pilishvili,K R H Praetorius,Isaiah G Reed,Rachel L. Severson,Nekabari Sigalo,Emma Suzanne Stanislawski,Sarah Stich,Buddhi Tilakaratne,Kathryn Turner,Caleb Wiedeman,Allison Zaldivar,Benjamin J. Silk,Heather M. Scobie +61 more
TL;DR: In this article , the authors compared the impact of original (monovalent) COVID-19 vaccines and bivalent boosters and found that those who had received a bivalent booster received during the preceding 2 weeks-2 months improved protection against death.
Journal ArticleDOI
Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023
Heather M. Scobie,Akilah R. Ali,Phillip Shirk,Zachary R. Smith,Prabasaj Paul,Clinton R. Paden,N. Hassell,Xiao-yu Zheng,Anastasia S. Lambrou,Rebecca Kondor,Duncan MacCannell,Natalie J. Thornburg,Joseph D. Miller,David E. Wentworth,Benjamin J. Silk +14 more
TL;DR: In this article , the SARS-CoV-2 Alpha variant emerged in late 2020, a spike gene deletion (Δ69-70) in the N-terminal region, which might compensate for immune escape mutations that impair infectivity, resulted in reduced or failed S-gene target amplification in certain multitarget reverse transcription-polymerase chain reaction (RT-PCR) assays.
Journal ArticleDOI
Estimated preventable COVID-19-associated deaths due to non-vaccination in the United States
Katherine Min Jia,William P. Hanage,Marc Lipsitch,Amelia G Johnson,Avnika B. Amin,Akilah R. Ali,Heather M. Scobie,David L. Swerdlow +7 more
TL;DR: In this article , the authors used a simple method based on a nationally representative dataset to estimate the preventable deaths among unvaccinated individuals in the US from May 30, 2021 to September 3, 2022 adjusted for the effects of age and time.